|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| 25-06-01 | Octopus Biosafety SA Auditor Raises 'Going Concern' Doubt | CI |
| 25-06-01 | Octopus Biosafety SA Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
Revenues | 662K | 537K | 277K | 656K | 385K | |
Other Revenues, Total | 1 | 2 | 1 | -1 | 1 | |
Total Revenues | 662K | 537K | 277K | 656K | 385K | |
Cost of Goods Sold, Total | 861K | 482K | 333K | 726K | 721K | |
Gross Profit | -199K | 54.8K | -55.13K | -69.95K | -336K | |
Selling General & Admin Expenses, Total | 714K | 663K | 434K | 482K | 467K | |
Depreciation & Amortization - (IS) | 477K | 511K | 249K | 899K | 683K | |
Other Operating Expenses | 10.92K | 374 | -11.99K | -12.95K | -648K | |
Other Operating Expenses, Total | 1.2M | 1.17M | 671K | 1.37M | 501K | |
Operating Income | -1.4M | -1.12M | -726K | -1.44M | -837K | |
Interest Expense, Total | -8.91K | -8.83K | -4.61K | -3.46K | -1.22K | |
Interest And Investment Income | - | - | - | - | - | |
Net Interest Expenses | -8.91K | -8.83K | -4.61K | -3.46K | -1.22K | |
Currency Exchange Gains (Loss) | -27 | 68 | - | - | - | |
Other Non Operating Income (Expenses) | - | - | -2 | 1 | -1 | |
EBT, Excl. Unusual Items | -1.41M | -1.13M | -731K | -1.44M | -839K | |
Gain (Loss) On Sale Of Assets | -30K | -78.03K | 67.37K | 32.06K | 0 | |
Other Unusual Items | 378K | -50.21K | -296K | -559K | -29.47K | |
EBT, Incl. Unusual Items | -1.06M | -1.26M | -960K | -1.97M | -868K | |
Income Tax Expense | -230K | -246K | -157K | -191K | -209K | |
Earnings From Continuing Operations | -832K | -1.01M | -803K | -1.78M | -659K | |
Net Income to Company | -832K | -1.01M | -803K | -1.78M | -659K | |
Net Income - (IS) | -832K | -1.01M | -803K | -1.78M | -659K | |
Net Income to Common Incl Extra Items | -832K | -1.01M | -803K | -1.78M | -659K | |
Net Income to Common Excl. Extra Items | -832K | -1.01M | -803K | -1.78M | -659K | |
Per Share Items | ||||||
Net EPS - Basic | -0.21 | -0.25 | -0.2 | -0.12 | -0.04 | |
Basic EPS - Continuing Operations | -0.21 | -0.25 | -0.2 | -0.12 | -0.04 | |
Basic Weighted Average Shares Outstanding | 4.06M | 4.06M | 4.06M | 14.78M | 14.98M | |
Net EPS - Diluted | -0.21 | -0.25 | -0.2 | -0.12 | -0.04 | |
Diluted EPS - Continuing Operations | -0.21 | -0.25 | -0.2 | -0.12 | -0.04 | |
Diluted Weighted Average Shares Outstanding | 4.06M | 4.06M | 4.06M | 14.78M | 14.98M | |
Normalized Basic EPS | -0.22 | -0.17 | -0.11 | -0.06 | -0.03 | |
Normalized Diluted EPS | -0.22 | -0.17 | -0.11 | -0.06 | -0.03 | |
Supplemental Items | ||||||
EBITDA | -924K | -609K | -477K | -539K | -155K | |
EBITA | -1.4M | -1.12M | -726K | -1.44M | -837K | |
EBIT | -1.4M | -1.12M | -726K | -1.44M | -837K | |
Total Revenues (As Reported) | 645K | 578K | 399K | 596K | 975K | |
Effective Tax Rate - (Ratio) | 21.68 | 19.6 | 16.34 | 9.71 | 24.08 | |
Normalized Net Income | -881K | -705K | -457K | -901K | -524K |
- Stock Market
- Stocks
- MLOCT Stock
- Stock
- Financials Octopus Robots
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















